SCN5A and channelopathy: The presence of anti-NaV1.5 IgGs was also investigated in a cohort of 35 patients with other cardiac diseases, including channelopathies such as long QT syndrome, heart failure, and cardiomyopathies (see Supplementary data online, Table S3).